Back

Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy

27 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Coronary artery disease: from bench to bedside Thrombosis and coagulation ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Gerald Chi

Harvard Medical School, Boston (United States of America)

71 More presentations in this session

Presentation thumbnail
Professor P. Pignatelli Spinazzola (Rome, IT)
Abstract Slides
Presentation thumbnail
Doctor B. Mahmoodi (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Professor L. Rallidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Doctor J. Adjedj (Saint Laurent du Var, FR)
Abstract Slides
Presentation thumbnail
Professor K. Karamfiloff (Sofia, BG)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Coronary artery disease: from bench to bedside

The Event

Event poster

ESC Congress 2017

27 August 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources